| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1586/14787210.3.2.229 |
| P698 | PubMed publication ID | 15918780 |
| P2093 | author name string | Yves Benhamou | |
| P2860 | cites work | Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B | Q28212394 |
| Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients | Q28375088 | ||
| Dose range study of pharmacokinetics, safety, and preliminary antiviral activity of emtricitabine in adults with hepatitis B virus infection. | Q34109170 | ||
| Risk factors for severe hepatic injury after introduction of highly active antiretroviral therapy | Q34340792 | ||
| Nucleoside analogues for chronic hepatitis B: antiviral efficacy and viral resistance | Q34756218 | ||
| Interactions of the human immunodeficiency virus and the hepatotropic viruses | Q35230727 | ||
| A treatment algorithm for the management of chronic hepatitis B virus infection in the United States | Q35689607 | ||
| Treatment of chronic hepatitis B in the human immunodeficiency virus-infected patient: present and future | Q40541808 | ||
| Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids | Q40606293 | ||
| Inhibition of the replication of the DNA polymerase M550V mutation variant of human hepatitis B virus by adefovir, tenofovir, L-FMAU, DAPD, penciclovir and lobucavir | Q40887887 | ||
| Efficacy and safety of emtricitabine vs stavudine in combination therapy in antiretroviral-naive patients: a randomized trial | Q42631309 | ||
| Evaluation of chronic hepatitis B virus (HBV) infection in coinfected patients receiving lamivudine as a component of anti-human immunodeficiency virus regimens | Q43541564 | ||
| Peginterferon alpha-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B. | Q43695474 | ||
| Safety and efficacy of oral entecavir given for 28 days in patients with chronic hepatitis B virus infection. | Q43722501 | ||
| Increasing impact of chronic viral hepatitis on hospital admissions and mortality among HIV-infected patients | Q43969654 | ||
| Inhibitory activity of dioxolane purine analogs on wild-type and lamivudine-resistant mutants of hepadnaviruses | Q44116651 | ||
| Influence of HIV infection on the response to interferon therapy and the long-term outcome of chronic hepatitis B. | Q44231599 | ||
| Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B. | Q44329201 | ||
| Biologic Properties of Hepatitis B Viral Genomes with Mutations in the Precore Promoter and Precore Open Reading Frame | Q44401268 | ||
| Efficacy of tenofovir disoproxil fumarate in antiretroviral therapy-naive and -experienced patients coinfected with HIV-1 and hepatitis B virus | Q44583350 | ||
| Antiretroviral therapy and HIV/hepatitis B virus coinfection | Q44778142 | ||
| HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). | Q44933768 | ||
| Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial | Q44975155 | ||
| Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B. | Q45061899 | ||
| BHIVA Guidelines: coinfection with HIV and Chronic hepatitis B virus | Q45711101 | ||
| Dual efficacy of lamivudine treatment in human immunodeficiency virus/hepatitis B virus-coinfected persons in a randomized, controlled study (CAESAR). The CAESAR Coordinating Committee | Q45747996 | ||
| Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. | Q45750465 | ||
| Which patients with chronic hepatitis B virus infection will respond to alpha-interferon therapy? A statistical analysis of predictive factors | Q45843781 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 229-239 | |
| P577 | publication date | 2005-04-01 | |
| P1433 | published in | Expert Review of Anti-infective Therapy | Q15734432 |
| P1476 | title | HIV-1/hepatitis B coinfection | |
| P478 | volume | 3 |
Search more.